Biodesix (BDSX) Other Operating Expenses (2019 - 2026)

Biodesix has reported Other Operating Expenses for 8 years, with the latest figure at $4.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 11.49% year-over-year to $4.2 million; the trailing twelve-month figure through Mar 2026 stood at -$11.5 million (down 117.86% YoY), and the FY2025 full-year result was -$92.9 million, down 687.34% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $4.2 million, up from -$23.9 million in the prior quarter.
• The five-year high for Other Operating Expenses was $78.0 million in Q4 2024, with the low at -$23.9 million in Q4 2025.
• Historically, Other Operating Expenses has averaged $3.5 million across 5 years, with a median of $3.4 million in 2023.
• The largest YoY upside for Other Operating Expenses was 2194.82% in 2024 against a maximum downside of 758.45% in 2024.
• Biodesix's Other Operating Expenses stood at $3.3 million in 2022, then grew by 2.78% to $3.4 million in 2023, then soared by 2194.82% to $78.0 million in 2024, then plunged by 130.66% to -$23.9 million in 2025, then jumped by 117.61% to $4.2 million in 2026.
• The last three Other Operating Expenses figures came in at $4.2 million (Q1 2026), -$23.9 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.